about
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and ToxicityGenetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexesCharacterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patientEfficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara Region, Ethiopia.Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.Deciphering the recent phylogenetic expansion of the originally deeply rooted Mycobacterium tuberculosis lineage 7Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis.Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.Ebola vaccines - Where are we?Stability of a Vesicular Stomatitis Virus-Vectored Ebola Vaccine.Tuberculosis outbreak in Eastern Norway.Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.Tuberculosis Outbreak in an Educational Institution in Norway.Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.Diagnostic applications for Lassa fever in limited-resource settings
P50
Q28051937-DD4451C2-B156-4A04-A9C6-454A1A821CCEQ28607442-3B5B3C52-00F4-4B52-9C0B-B75B70F6C961Q33565201-6A45B07F-C2A0-4DDA-8C62-12A9FE8CCD64Q34073348-0C444D19-C20C-4C18-9C7D-61BA79D427E2Q34353041-2660EF8C-3AB2-4E3F-BA89-1C07009C8AE2Q34431744-34DD98A7-6794-4C3C-A6B1-B7755F374EA1Q34466858-B8F6D197-F9A7-4903-BDBB-09472C641C9AQ34488529-FA39B0EF-303F-45BE-803B-B8C46375BF6FQ34783257-A1F039AF-44BC-4B08-83DF-64304C9E760BQ35193130-0922CC9E-61FF-41F3-BB45-B51C5304E2AAQ35783511-D89C3455-9DFF-4C08-BE56-464F68AA0F1EQ35806559-75BD36DF-EC05-4BA0-83F0-ABB974C6E092Q35949585-2DC4826B-0888-4F35-841F-57FACE5661ADQ36065257-DAFBF560-489F-4886-AA26-C8A9323E3C98Q36418099-F81B01E6-556B-4543-B0D5-758F7D7F08B7Q37340824-C5447A5F-A745-4754-ACA6-04B3E3D70AE7Q37545048-13448F4B-4C73-4F20-8F7C-FCD4DD62F692Q37590858-BA718039-56F8-4723-A595-FE11DF161E4DQ38102475-71081F7E-E3AC-4009-BF55-E06C998A004AQ38606992-1C42C250-B1CC-4E14-A876-16437BB88505Q38684862-84462915-94A3-462D-9304-DC87B21A6B04Q39537767-8222F112-0A8D-47D4-AC9A-A1917B2235CCQ40091750-6FC876C7-D791-4A99-9997-2FC541B7CFF1Q40131125-E7CE6CD0-4B7E-479A-A4F9-6DCA7794A55FQ40868968-5AF2F8E7-A3B6-404E-91D7-DED6E83B54A7Q41705361-94094DC2-2868-4C36-B146-29A9B9DEF80CQ41992546-1EF0D037-D1F3-4E7C-AD64-E5B8D409BBC2Q42234518-D58E8ACD-4203-4883-B125-8254D1B7E5E0Q42244474-A38255B0-8960-42BC-BC80-86898CADF25AQ43683511-13ABF2E0-A065-4C3B-BD32-8ECA122D9271Q46265378-1EE2346A-9F95-453E-8925-340C581E627FQ49352391-87A9844D-3FDF-4763-A2A1-836E35245D75Q53675998-1FFCB27F-9869-4201-8D7D-5F8668AAE5EFQ64246749-7CB7B507-EA8A-406F-AF6C-91D68B92D512
P50
name
Gunnstein Norheim
@ast
Gunnstein Norheim
@en
Gunnstein Norheim
@es
Gunnstein Norheim
@nl
type
label
Gunnstein Norheim
@ast
Gunnstein Norheim
@en
Gunnstein Norheim
@es
Gunnstein Norheim
@nl
prefLabel
Gunnstein Norheim
@ast
Gunnstein Norheim
@en
Gunnstein Norheim
@es
Gunnstein Norheim
@nl